The DOI matches its Crossref record.
Sympathetics, insulin resistance and coronary risk in hypertension: the chicken-and-egg question
Abstract
From the Division of Hypertension, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These studies advanced the concept that the sympathetic nervous system promotes insulin resistance in skeletal muscle through hemodynamic mechanisms and that the interaction of insulin, the sympathetic nervous system and insulin sensitivity is a two way street88.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [88]
Citations
Cited by
Sorted by citations
Etiology and pathogenesis of preeclampsia: Current concepts
Dekker, G., & Sibai, B. M. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70160-7 · Cited by 760
Mechanisms of obesity-induced hypertension
Kotsis, V., Stabouli, S., Papakatsika, S., Rizos, Z., & Parati, G. (2010) · Hypertension Research · doi:10.1038/hr.2010.9 · Cited by 632
The Sympathetic Nervous System Alterations in Human Hypertension
Grassi, G., Mark, A., & Esler, M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303604 · Cited by 616
Masuo, K., Kawaguchi, H., Mikami, H., Ogihara, T., & Tuck, M. L. (2003) · Hypertension · doi:10.1161/01.hyp.0000091371.53502.d3 · Cited by 516
How to assess sympathetic activity in humans
Grassi, G., & Esler, M. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917060-00001 · Cited by 455
Mechanisms of Sympathetic Activation in Obesity-Related Hypertension
Esler, M., Straznicky, N., Eikelis, N., Masuo, K., Lambert, G., & Lambert, E. (2006) · Hypertension · doi:10.1161/01.hyp.0000242642.42177.49 · Cited by 443
The sympathetic nervous system and the metabolic syndrome
Mancia, G., Bousquet, P., Elghozi, J. L., Esler, M., Grassi, G., Julius, S., Reid, J., & Van Zwieten, P. A. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e328048d004 · Cited by 385
Self-citationAssessment of Sympathetic Cardiovascular Drive in Human Hypertension
Grassi, G. M. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.119883 · Cited by 340
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome
Grassi, G., Dell’Oro, R., Quarti-Trevano, F., Scopelliti, F., Seravalle, G., Paleari, F., Gamba, P. L., & Mancia, G. (2005) · Diabetologia · doi:10.1007/s00125-005-1798-z · Cited by 294
“Total serum cholesterol, triglycerides and HDL cholesterol (enzymatic method) and plasma glucose (standard glucose oxidase method) were assayed in the fasting state from a venous blood sample.Werecruited48subjects(37malesand11females)who displayed at least three of the five diagnostic criteria for the metabolic syndro…”
MethodBlack, P. H. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.04.008 · Cited by 289
Fewer nephrons at birth: A missing link in the etiology of essential hypertension?
Mackenzie, H. S., & Brenner, B. M. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90161-2 · Cited by 258
Neel, J. V., Weder, A. B., & Julius, S. (1998) · Perspectives in biology and medicine · doi:10.1353/pbm.1998.0060 · Cited by 252
Self-citationAutonomic imbalance, hypertension, and cardiovascular risk
Brook, R. H. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)00228-4 · Cited by 260
“No doubt the primary etiology of this complex web of abnormalities remains a chicken-and-egg riddle”
BackgroundOverweight and Hypertension: A 2-Way Street?
Julius, S., Valentini, M., & Palatini, P. (2000) · Hypertension · doi:10.1161/01.hyp.35.3.807 · Cited by 253
Self-citationJacob, S., Kristian, R. E. T. T., & HENRIKSEN, E. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00141-1 · Cited by 204
Masuo, K. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(96)00303-2 · Cited by 196
“Thus, investigations into the relationship between sympathetic nervous system activity and the insulin-resistant state or hyperinsulinemia in hypertensive patients tend to leave the “chicken-and-egg” question open, and, despite tremendous efforts, results have not yet been consistent”
BackgroundKumagai, H., Oshima, N., Matsuura, T., Iigaya, K., Imai, M., Onimaru, H., Sakata, K., Osaka, M., Onami, T., Takimoto, C., et al. (2011) · Hypertension Research · doi:10.1038/hr.2011.208 · Cited by 183
The underlying mechanisms for development of hypertension in the metabolic syndrome
Yanai, H., Tomono, Y., Ito, K., Furutani, N., Yoshida, H., & Tada, N. (2008) · Nutrition Journal · doi:10.1186/1475-2891-7-10 · Cited by 171
“Elevated resting heat rates [20,21], and baroreflex dysfunction have been reported to play an important role in development of hypertension in the metabolic syndrome [22].”
Weight Gain–Induced Blood Pressure Elevation
Masuo, K., Mikami, H., Ogihara, T., & Tuck, M. L. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1135 · Cited by 155
Effect of Calcium Antagonists on Plasma Norepinephrine Levels, Heart Rate, and Blood Pressure
Grossman, E., & Messerli, F. H. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00722-4 · Cited by 145
Shigetoh, Y., Adachi, H., Yamagishi, S., Enomoto, M., Fukami, A., Otsuka, M., Kumagae, S., Furuki, K., Nanjo, Y., & Imaizumi, T. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2008.331 · Cited by 146
Insulin resistance and sympathetic overactivity in women
Kaaja, R., & Pöyhönen‐Alho, M. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000194121.19851.e5 · Cited by 139
Palatini, P., Dorigatti, F., Zaetta, V., Mormino, P., Mazzer, A., Bortolazzi, A., D'Este, D., Pegoraro, F., Milani, L., & Mos, L. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000242413.96277.5b · Cited by 131
Prolonged Activation of the Baroreflex Abolishes Obesity-Induced Hypertension
Lohmeier, T. E., Dwyer, T. M., Irwin, E. D., Rossing, M. A., & Kieval, R. S. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.087874 · Cited by 118
Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity?
Lambert, É., Straznicky, N. E., Dixon, J. B., & Lambert, G. W. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00096.2015 · Cited by 117
Björklund‐Bodegârd, K., Lind, L., Vessby, B. O., Andrén, B., & Lithell, H. (2002) · Circulation · doi:10.1161/01.cir.0000019737.87850.5a · Cited by 116
The changing face of sympathetic overactivity in hypertension
Julius, S., & Majahalme, S. K. (2000) · Annals of Medicine · doi:10.3109/07853890008995939 · Cited by 113
Self-citationWang, L., Cui, L., Wang, Y., Vaidya, A., Chen, S., Zhang, C., Zhu, Y., Li, D., Hu, F. B., Wu, S., et al. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv079 · Cited by 107
Adaptation, allometry, and hypertension.
Weder, A. B., & Schork, N. J. (1994) · Hypertension · doi:10.1161/01.hyp.24.2.145 · Cited by 100
Epidemiology of Risk Factors for Hypertension
Kornitzer, M., Dramaix, M., & Backer, G. D. (1999) · Drugs · doi:10.2165/00003495-199957050-00003 · Cited by 99
Hypertension in Adult American Indians
Howard, B. V., Lee, E. T., Yeh, J. L., Go, O. T., Fabsitz, R. R., Devereux, R. B., & Welty, T. K. (1996) · Hypertension · doi:10.1161/01.hyp.28.2.256 · Cited by 99
The Evidence for a Pathophysiologic Significance of the Sympathetic Overactivity in Hypertension
Julius, S. (1996) · Clinical and Experimental Hypertension · doi:10.3109/10641969609088965 · Cited by 89
Self-citationLeptin and mechanisms of endothelial dysfunction and cardiovascular disease
Knudson, J. D., Payne, G. A., Borbouse, L., & Tune, J. D. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0082-2 · Cited by 90
“A review by Julius and Jamerson [ 28 ] nicely describes the relationship between hypertension and insulin resistance.”
BackgroundMima, A. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.04.011 · Cited by 91
Hyperinsulinemia in glucose-tolerant women with preeclampsia A controlled study
Abundis, E. M. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00448-3 · Cited by 88
Heart Rate, Sympathetic Cardiovascular Influences, and The Metabolic Syndrome
Grassi, G. M., Arenare, F., Quarti‐Trevano, F., Seravalle, G., & Mancia, G. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.05.007 · Cited by 79
Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation
Carnagarin, R., Kiuchi, M. G., Ho, J. K., Matthews, V. B., & Schlaich, M. P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01058 · Cited by 81
Heart Rate and Subsequent Blood Pressure in Young Adults
Kim, J.-R., Kiefe, C. I., Liu, K., Williams, O. D., Jacobs, D. R., & Oberman, A. (1999) · Hypertension · doi:10.1161/01.hyp.33.2.640 · Cited by 79
Genetically Complex Cardiovascular Traits
Schork, N. J. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.145 · Cited by 64
The Role of the Autonomic Nervous System in Hypertension.
Amerena, J., & Julius, S. (1995) · Hypertension Research · doi:10.1291/hypres.18.99 · Cited by 63
Self-citationReactivity as a Predictor of Subsequent Blood Pressure
Knox, S. S., Hausdorff, J. M., & Markovitz, J. H. (2002) · Hypertension · doi:10.1161/01.hyp.0000041417.94797.57 · Cited by 62
Temporal Relations between Obesity and Insulin: Longitudinal Data from the Normative Aging Study
Lazarus, R. M., Sparrow, D., & Weiss, S. T. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009431 · Cited by 57
“The complex relations among sympathetic nervous activity, insulin, and essential hypertension have been described (20) as a "chicken and egg" situation.”
Consequences of the Increased Autonomic Nervous Drive in Hypertension, Heart Failure and Diabetes
Julius, M. (1998) · Blood Pressure · doi:10.1080/080370598438410-1 · Cited by 55
Lefrandt, J. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02218-x · Cited by 53
The potential role of adenosine in the pathophysiology of the insulin resistance syndrome
Bakker, S. J. L., Gans, R. O. B., ter Maaten, J. C., Teerlink, T., Westerhoff, H. V., & Heine, R. J. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00745-0 · Cited by 52
Konda, T., Enomoto, A., Matsushita, J., et al. (2005) · Nephron Physiology · doi:10.1159/000085713 · Cited by 50
Neurogenic essential hypertension revisited: the case for increased clinical and research attention
Mann, S. J. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)00978-6 · Cited by 49
“It also confers the advantage of modifying adrenergic effects on atherosclerosis, thrombosis, insulin resistance, and hyperlipidemia.(97) Nevertheless, this regimen has received little attention as a management alternative.”
BackgroundAntihypertensive Drugs and the Sympathetic Nervous System
Colle, S. D., Morello, F., Rabbia, F., Milan, A., Naso, D., Puglisi, E., Mulatero, P., & Veglio, F. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318135446c · Cited by 49
“Beyond SNS effects, antiadrenergic combination therapy also confers the advantage of interfering with the adrenergic effects on atherosclerosis, thrombosis, insulin resistance, and hyperlipidemia.(88,89) Nevertheless, this regimen has received little attention as a management alternative.”
BackgroundLipid Peroxidation in Pregnancy with Preeclampsia and Diabetes
Kharb, S. (2000) · Gynecologic and Obstetric Investigation · doi:10.1159/000010294 · Cited by 49
Familial Hypertension, Insulin, Sympathetic Activity, and Blood Pressure Elevation
Masuo, K., Mikami, H., Ogihara, T., & Tuck, M. L. (1998) · Hypertension · doi:10.1161/01.hyp.32.1.96 · Cited by 47
Job strain and risk indicators for cardiovascular disease in young female nurses.
Riese, H., Houtman, I. L. D., van Doornen, L. J. P., et al. (2000) · Health Psychology · doi:10.1037//0278-6133.19.5.429 · Cited by 46
Wang, X., Ren, J., Ren, H., Song, W., Qiao, Y., Zhao, Y., Linghu, L., Cui, Y. Y., Zhao, Z., Chen, L., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40036-5 · Cited by 48
“Sympathetic activation may be the most important of many mechanisms leading to increased risk of DM 76 , causing vasoconstriction and reducing blood flow to skeletal muscle, leading to impaired skeletal muscle glucose uptake 77 .”
BackgroundThe complex interaction between overweight, hypertension, and sympathetic overactivity
Feldstein, C. A., & Julius, S. (2009) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2009.10.001 · Cited by 42
Self-citationMechanism of differential effects of antihypertensive agents on serum lipids
Brook, R. D. (2000) · Current Hypertension Reports · doi:10.1007/s11906-000-0040-0 · Cited by 40
Julius, S. (1995) · Clinical and Experimental Hypertension · doi:10.3109/10641969509087078 · Cited by 37
Self-citationDietary salt restriction increases vascular insulin resistance*
Feldman, R. D., Logan, A. G., & Schmidt, N. D. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90201-5 · Cited by 36
Job strain and risk indicators for cardiovascular disease in young female nurses.
Riese, H., Houtman, I. L. D., van Doornen, L. J. P., et al. (2000) · Health Psychology · doi:10.1037/0278-6133.19.5.429 · Cited by 37
Sohn, R. E., & Jenei‐Lanzl, Z. (2023) · NeuroImmunoModulation · doi:10.1159/000531798 · Cited by 37
“Moreover, the fact that elevated plasma NE concentrations in young adulthood predisposed for future weight gain suggests that, in turn, increased SNS activity may cause obesity [199, 200].”
BackgroundEffects of metformin on endothelial health and erectile dysfunction
Patel, J. P., Lee, E. H., Mena, C. I., & Walker, C. N. (2017) · Translational Andrology and Urology · doi:10.21037/tau.2017.03.52 · Cited by 33
“While elsewhere in the literature, interventions aimed at improving insulin sensitivity, for example through weight loss, have been shown to decrease sympathetic hyperactivity (31-33).”
BackgroundObesity-related hypertension: Role of the sympathetic nervous system, insulin, and leptin
Masuo, K. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0035-0 · Cited by 33
Moan, A., Høieggen, A., Nordby, G., Os, I., Eide, I. A., & Kjeldsen, S. E. (1995) · Metabolism · doi:10.1016/0026-0495(95)90034-9 · Cited by 32
Prevalence of Metabolic Syndrome in Young Men in Japan
Saito, I., Mori, M., Shibata, H., Hirose, H., Tsujioka, M., & Kawabe, H. (2007) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.14.27 · Cited by 30
Racial and Ethnic Inequalities in Health: Environmental, Psychosocial, and Physiological Pathways
Singer, B. H., & Ryff, C. D. (1997) · Springer eBooks · doi:10.1007/978-1-4612-0669-9_5 · Cited by 31
Caldiz, C. I., & de Cingolani, G. E. C. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90203-2 · Cited by 27
Parental Hyperdynamic Circulation Predicts Insulin Resistance in Offspring
Palatini, P., Vriz, O., Nesbitt, S. D., Amerena, J. V., Majahalme, S. K., Valentini, M., & Julius, S. (1999) · Hypertension · doi:10.1161/01.hyp.33.3.769 · Cited by 25
Self-citationIncreased plasma norepinephrine levels in previously pre-eclamptic women
Lampinen, K., Rönnback, M., Groop, P., Nicholls, M. G., Yandle, T. G., & Kaaja, R. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.84 · Cited by 22
Low-dose α/β blockade in the treatment of essential hypertension
Mann, S. J. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01302-9 · Cited by 21
Ishizawa, K., Yoshizumi, M., Tsuchiya, K., Takishita, E., Nakaya, Y., Kishi, K., Ebina, Y., Houchi, H., Minakuchi, K., & Tamaki, T. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01405-4 · Cited by 21
Harada, N., Onaka, M., Sakamoto, S., Niwa, Y., & Nakaya, Y. (1999) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007827720807 · Cited by 20
Mancia, G., & Grassi, G. M. (2009) · Journal of Hypertension · doi:10.1097/01.hjh.0000354420.23557.e2 · Cited by 19
Hausberg, M., Sinkey, C. A., MARK, A., Hoffman, R. P., & ANDERSON, E. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00146-0 · Cited by 19
Sympathetic Overactivation in Patients With Essential Hypertension and Hepatic Iron Overload
Seravalle, G., Dell’Oro, R., Quarti‐Trevano, F., Spaziani, D., Bertoli, S. V., Airoldi, F., Mancia, G., & Grassi, G. M. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15511 · Cited by 18
“One limitation is that our data did not allow us to clarify the socalled chicken-and-egg question, that is, whether the insulin resistance state and the concomitant metabolic alterations were the cause or rather the consequence of the sympathetic activation.(37,38) A further limitation refers to the fact that we could…”
BackgroundAutonomic responses to stress in B lack versus C aucasian A fricans: The SABPA Study
Reimann, M., Hamer, M., Schlaich, M. P., Malan, N. T., Rüdiger, H., Ziemssen, T., & Malan, L. (2011) · Psychophysiology · doi:10.1111/j.1469-8986.2011.01328.x · Cited by 16
Grandinetti, A., Liu, D. M., & Kaholokula, J. K. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0161-2 · Cited by 16
Clinical utility of sympathetic blockade in cardiovascular disease management
Park, C. S., & Lee, H. (2017) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2017.1307736 · Cited by 14
Prevalence of hyperinsulinemia in young, nonobese Japanese men
Masuo, K., Mikami, H., Ogihara, T., & Tuck, M. L. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715020-00006 · Cited by 13
Combined effect of ACE inhibitor and exercise training on insulin resistance in type 2 diabetic rats
Harada, N., Takishita, E., Ishimura, N., Minami, A., Sakamoto, S., & Nakaya, Y. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01495-9 · Cited by 13
Assessment of hypertension-mediated organ damage in children and adolescents with hypertension
Pac, M., Obrycki, Ł., Koziej, J., Skoczyński, K., Starnawska-Bojsza, A., & Litwin, M. (2023) · Blood Pressure · doi:10.1080/08037051.2023.2212085 · Cited by 13
Metabolic effects of moxonidine and other centrally acting antihypertensives
Schächter, M. (1999) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.1999.00042.x · Cited by 12
Effects of hyperinsulinemia on sympathetic responses to mental stress
Høieggen, A. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00146-6 · Cited by 12
Human Genome Evolution and Development of Cardiovascular Risk Factors Through Natural Selection
Poledne, R., & Zicha, J. (2018) · Physiological Research · doi:10.33549/physiolres.933885 · Cited by 12
Clinical Consequences of the Autonomic Imbalance in Hypertension and Congestive Heart Failure
Julius, S. (1998) · Scandinavian Cardiovascular Journal · doi:10.1080/14017439850140300-1 · Cited by 12
Self-citationCircadian variability of rate-pressure product in essential hypertension with enalapril therapy
Siègelovà, J., Fišer, B., Dušek, L., et al. (2000) · Cited by 11
Relationship of muscle sympathetic nerve activity to insulin sensitivity
Curry, T. B., Hines, C. N., Barnes, J. N., Somaraju, M., Basu, R., Miles, J. M., Joyner, M. J., & Charkoudian, N. (2014) · Clinical Autonomic Research · doi:10.1007/s10286-014-0235-0 · Cited by 9
“sympathetic activity lead to insulin resistance [19] and contribute to the development or worsening of comorbidities such as hypertension [23].”
Sympathetic Control of Circulation in Hypertension and Congestive Heart Failure
Lanfranchi, A. K. (1998) · Blood Pressure · doi:10.1080/080370598438474 · Cited by 9
Kario, K., Saito, I., Kushiro, T., Teramukai, S., Mori, Y., Hiramatsu, K., Kobayashi, F., & Shimada, K. (2013) · Journal of Clinical Hypertension · doi:10.1111/jch.12132 · Cited by 8
Habitual coffee intake reduces all-cause mortality by decreasing heart rate
Nohara‐Shitama, Y., Adachi, H., Enomoto, M., Fukami, A., Nakamura, S., Kono, S., Morikawa, N., Sakaue, A., Hamamura, H., Toyomasu, K., et al. (2019) · Heart and Vessels · doi:10.1007/s00380-019-01422-0 · Cited by 8
Role of the Nervous System in Human Hypertension
Amerena, J. V., & Julius, S. (2003) · doi:10.1007/978-1-4615-6493-5_2 · Cited by 8
Self-citationNürnberger, J., Dammer, S., Philipp, T., Wenzel, R. R., & Schäfers, R. F. (2003) · Cardiovascular Diabetology · doi:10.1186/1475-2840-2-7 · Cited by 8
“However, it is a matter of ongoing debate, whether this disturbance of glucose metabolism contributes pathogenetically to the development of enhanced total peripheral resistance as the haemodynamic hallmark of hypertension or whether, vice versa, impaired glucose tolerance is a mere consequence of the haemodynamic cha…”
Central Sympathetic Inhibition: a Neglected Approach for Treatment of Cardiac Arrhythmias?
Cagnoni, F., Destro, M., Bontempelli, E., Locatelli, G., Hering, D., & Schlaich, M. P. (2016) · Current Hypertension Reports · doi:10.1007/s11906-015-0619-0 · Cited by 7
“pathophysiological changes that precedes the development of insulin-resistance and obesity, as shown in offspring studies and prospective cohort studies [47-51].”
BackgroundHipertensión arterial en el paciente dislipémico
Cia, P., Armario, P., Badimón, L., & Redón, J. (2001) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(01)78798-0 · Cited by 7
“Otros meca-nismos que pueden intervenir en esta relación serían el incremento del tono adrenérgico o la resistencia a la insulina, que a su vez podrían estar interrelaciona-dos 19 .”
Cardiovascular and sympathetic effects of reversing insulin resistance in hypertension
Grassi, G. M. (2004) · Journal of Hypertension · doi:10.1097/00004872-200409000-00007 · Cited by 6
Kanai, T., & Krum, H. (2013) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.06.002 · Cited by 5
SYMPATHETIC OVERACTIVITY AND CORONARY RISK IN HYPERTENSION
Amerena, J. V., & Julius, S. (1997) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1997.tb00882.x · Cited by 5
Self-citationKanai, T., & Krum, H. (2013) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.06.001 · Cited by 4
Hypertension and Insulin Resistance
Natali, A., Taddei, S., & Ferrannini, E. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-3906-0_16 · Cited by 4
Hipertensión arterial en el paciente dislipidémico
Gómez, P., García, P. A., Badimón, L., & Mas, J. R. I. (2002) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(02)71274-9 · Cited by 4
The Sympatho-Adrenal System in the Metabolic Syndrome
Landsberg, L. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_6 · Cited by 3
Chan, P., Wang, C., Lin, T., et al. (1995) · International Journal of Cardiology · doi:10.1016/0167-5273(95)02321-m · Cited by 3
Involvement of Renal Sympathetic Nerve in Pathogenesis of Hypertension
Kumagai, H., Onami, T., Iigaya, K., Takimoto, C., Imai, M., Matsuura, T., Sakata, K., Oshima, N., Hayashi, K., & Saruta, T. (2004) · KARGER eBooks · doi:10.1159/000078710 · Cited by 3
Metadata
- Authors
- Julius, S., & Jamerson, K.
- Affiliations
- University of Michigan (US)
- ORCID
- Jamerson, Kenneth
- Venue
- Journal of Hypertension
- Published
- 1994-05
- Volume
- 12
- Issue
- 5
- Pages
- 495???502
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W2077171413
- Cited by
- 127
- References
- 0
- Citations by year
- 2024: 2 · 2023: 3 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 6 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 2 · 2013: 4
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r37hl037464-10)
- National Heart, Lung, and Blood Institute
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Keywords
- sympathetic nervous system, insulin resistance, coronary heart disease risk, hypertension
- MeSH terms
- Animals, Coronary Disease, Humans, Hypertension, Insulin Resistance, Risk Factors, Sympathetic Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review